Lista de obras - C Willekens - Dominio Público Uruguay

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset

artículo científico publicado en 2018

An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report.

artículo científico

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).

artículo científico publicado en 2015

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

scientific article published on 20 March 2019

Bone marrow necrosis: a culture medium for bacteria

artículo científico publicado en 2013

Bortezomib and Waldenstrom's macroglobulinemia

artículo científico publicado en 2009

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

artículo científico publicado en 2012

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

artículo científico publicado en 2015

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

scientific article published on 16 July 2018

Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.

artículo científico publicado en 2015

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML

article

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study

artículo científico publicado en 2020

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2017

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines

artículo científico publicado en 2017

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

artículo científico publicado en 2020

Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report.

artículo científico publicado en 2011

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

artículo científico publicado en 2016

Identification of a new mutation on the beta-globin gene: codons 8/9 (+AGAA); GAG.AAG.TCT(Glu-Lys-Ser)>GAG. AAAGAAG, in a patient from the north of France with a phenotype of beta-thalassemia minor

artículo científico publicado en 2010

Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

artículo científico publicado en 2016

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.

artículo científico publicado en 2014

Linezolid induces ring sideroblasts

artículo científico publicado en 2013

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

artículo científico publicado en 2014

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

artículo científico publicado en 2018

Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.

artículo científico publicado en 2017

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.

artículo científico publicado en 2018

Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.

artículo científico publicado en 2015

Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors

artículo científico publicado en 2014

Prognostic value of PINI index in patients with multiple myeloma.

artículo científico publicado en 2012

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

artículo científico publicado en 2015

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab.

artículo científico publicado en 2015

Retroperitoneal fibrosis as extramedullary hematopoiesis of a chronic myelomonocytic leukemia

artículo científico publicado en 2018

Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus

artículo científico publicado en 2015

Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia

artículo científico publicado en 2010

Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease.

artículo científico publicado en 2017

Lista de obras de C Willekens

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset

An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report.

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia

Bone marrow necrosis: a culture medium for bacteria

Bortezomib and Waldenstrom's macroglobulinemia

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report.

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

Identification of a new mutation on the beta-globin gene: codons 8/9 (+AGAA); GAG.AAG.TCT(Glu-Lys-Ser)>GAG. AAAGAAG, in a patient from the north of France with a phenotype of beta-thalassemia minor

Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.

Linezolid induces ring sideroblasts

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.

Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.

Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors

Prognostic value of PINI index in patients with multiple myeloma.

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab.

Retroperitoneal fibrosis as extramedullary hematopoiesis of a chronic myelomonocytic leukemia

Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus

Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia

Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease.